CME and CFTC Engage in Heated Battle Over On-Chain Perpetual Futures

The conflict between the CME Group and the US Commodity Futures Trading Commission (CFTC) has intensified, with the CME suing the CFTC over its decision to allow blockchain-based perpetual futures products. The CME argues that these products, which enable users to speculate on asset prices with leverage and no expiration date, are being mislabeled and misregulated. The dispute has significant implications for the US approach to the rapidly growing market, with non-US perpetual futures volume reportedly reaching $60 trillion in 2023. The CME claims that the CFTC's sudden embrace of perpetual futures did not consider the potential consequences and will harm its long-dated futures products. The CFTC, on the other hand, believes that its approach will allow for greater innovation and competition in the market. The lawsuit has sparked a heated debate, with some arguing that the CME is attempting to stifle innovation and maintain its dominance in the market, while others believe that the CFTC is overstepping its authority and failing to properly regulate the market. As the case awaits federal court action, the future of CFTC-driven perpetual futures remains uncertain.